Source BioScience, comprised of Source LDPath and Source Genomics, provides industry-leading laboratory services in Genomics and Histopathology, partnering with biotechnology, pharmaceutical, healthcare and academia. Source LDPath provides an end-to-end clinical diagnostic service, from histopathology, including digital pathology and AI, through to molecular diagnostic services. Source LDPath alre
ady supports over 85 NHS Trusts and a comprehensive network of Private Healthcare clinics to expand their diagnostic capabilities, ensuring diagnostic results are delivered within clinically actionable timeframes. Source LDPath brings pioneering expertise in digital pathology and AI implementation, helping NHS pathology departments digitise their workflows for streamlined operations and greater diagnostic reporting capacity, tailoring integration touchpoints to the specific requirements of the Hospital or Trust.
• Cellular and digital pathology wet laboratory processing
• Reporting - access a pool of over 200 specialist consultant pathologists
• MDM and Second Opinions
• Digital Implementation Support with AI integration
• Connectivity and LIMS integration with Source HIVE™
Source Genomics provides a broad portfolio of multi-omic services, delivering high-quality data in Genomics, Spatial Transcriptomics, Proteomics and Epigenomics. Market-leaders in Sanger Sequencing and Next-Generation Sequencing Services, Source Genomics delivers bespoke laboratory expertise to excel your project at rapid turnaround times.
• Sanger Sequencing
• NGS - WGS, WES, RNA-seq
• Oxford Nanopore Sequencing
• Olink proteomics
• Optical Genome Mapping
• 10x Genomics Visium
• Bioinformatics
• And more
